Should we change strategy for adjuvant therapy according to surgery type in stage II–IIIA non-small cell lung cancer?
@article{ACTR8838,
author = {Taichi Matsubara and Gouji Toyokawa},
title = {Should we change strategy for adjuvant therapy according to surgery type in stage II–IIIA non-small cell lung cancer?},
journal = {AME Clinical Trials Review},
volume = {2},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/8838}
}